共 50 条
Screening for Atrial Fibrillation in Older Adults at Primary Care Visits: VITAL-AF Randomized Controlled Trial
被引:60
|作者:
Lubitz, Steven A.
[1
,2
,5
]
Atlas, Steven J.
[3
]
Ashburner, Jeffrey M.
[3
,5
]
Lipsanopoulos, Ana T. Trisini
[4
]
Borowsky, Leila H.
[3
]
Guan, Wyliena
[6
]
Khurshid, Shaan
[1
,2
,5
]
Ellinor, Patrick T.
[1
,2
,5
]
Chang, Yuchiao
[3
,5
]
McManus, David D.
[7
]
Singer, Daniel E.
[3
,5
]
机构:
[1] Massachusetts Gen Hosp, Cardiovasc Res Ctr, 55 Fruit St,GRB 109, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Demoulas Ctr Cardiac Arrhythmias, Boston, MA 02114 USA
[3] Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA
[4] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA
[5] Harvard Med Sch, Boston, MA 02115 USA
[6] Univ N Carolina, Chapel Hill, NC 27515 USA
[7] Univ Massachusetts, Med Sch, Dept Med, Worcester, MA USA
关键词:
atrial fibrillation;
digital health;
electrocardiography;
screening;
ORAL ANTICOAGULATION;
RISK-FACTOR;
STROKE;
THROMBOEMBOLISM;
RATIONALE;
DIAGNOSIS;
DESIGN;
DEVICE;
ECG;
D O I:
10.1161/CIRCULATIONAHA.121.057014
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
BACKGROUND: Undiagnosed atrial fibrillation (AF) may cause preventable strokes. Guidelines differ regarding AF screening recommendations. We tested whether point-of-care screening with a handheld single-lead ECG at primary care practice visits increases diagnoses of AF. METHODS: We randomized 16 primary care clinics 1:1 to AF screening using a handheld single-lead ECG (AliveCor KardiaMobile) during vital sign assessments, or usual care. Patients included were ages >= 65 years. Screening results were provided to primary care clinicians at the encounter. All confirmatory diagnostic testing and treatment decisions were made by the primary care clinician. New AF diagnoses during the 1-year follow-up were ascertained electronically and manually adjudicated. Proportions and incidence rates were calculated. Effect heterogeneity was assessed. RESULTS: Of 30 715 patients without prevalent AF (n=15 393 screening [91% screened], n=15 322 control), 1.72% of individuals in the screening group had new AF diagnosed at 1 year versus 1.59% in the control group (risk difference, 0.13% [95% CI, -0.16 to 0.42]; P=0.38). In prespecified subgroup analyses, new AF diagnoses in the screening and control groups were greater among those aged >= 85 years (5.56% versus 3.76%, respectively; risk difference, 1.80% [95% CI, 0.18 to 3.30]). The difference in newly diagnosed AF between the screening period and the previous year was marginally greater in the screening versus control group (0.32% versus -0.12%; risk difference, 0.43% [95% CI, -0.01 to 0.84]). The proportion of individuals with newly diagnosed AF who were initiated on oral anticoagulants was not different in the screening (n=194, 73.5%) and control (n=172, 70.8%) arms (risk difference, 2.7% [95% CI, -5.5 to 10.4]). CONCLUSIONS: Screening for AF using a single-lead ECG at primary care visits did not affect new AF diagnoses among all individuals aged 65 years or older compared with usual care.
引用
收藏
页码:946 / 954
页数:9
相关论文